Protecting a blockbuster diabetes treatment for AstraZeneca
AstraZeneca AB
Major victories across IP venues for Volkswagen, Audi, Bentley, and Lamborghini
Audi AG; Audi of America, LLC; Automobili Lamborghini America, LLC; Automobili Lamborghini S.p.A.; Bentley Motors Limited; Bentley Motors, Inc; Volkswagen AG; Volkswagen Group of America, Inc.
No confusion in trademark victory on summary judgment for the American Retirement Association
American Retirement Association
Finnegan helps Intellia Therapeutics acquire Rewrite Therapeutics, Inc. for $45 million
Intellia Therapeutics, Inc.
Finnegan secures favorable ITC ruling related to innovative electric SUVs for BMW
BMW of North America, LLC and Bayerische Motoren Werke AG
Finnegan fights for Sony’s “exceedingly famous” mark
Sony Group Corporation
Experience
Duchesnay Inc. v. Actavis Laboratories FL, Inc. et al. Duchesnay Inc. v. Actavis Laboratories FL, Inc. et al.
1:18-cv-01895, D. Del., Judges Andrews, Fallon
Experience
Teva Pharmaceuticals International GmbH v. Eli Lilly and Company Teva Pharmaceuticals International GmbH v. Eli Lilly and Company
1:18-cv-12029, D. Mass., Judge Burroughs
Experience
Alzheimer's Institute of America, Inc. v. Avid Radiopharmaceuticals Alzheimer's Institute of America, Inc. v. Avid Radiopharmaceuticals
2:10-cv-06908, E.D. Pa., Judges Angell, Savage, Cohen (Special Master)
13-1544, 16-2647, Fed. Cir., Judges Hughes, Lourie, Moore, Newman, Plager
Experience
Eli Lilly and Company v. Actavis Labs. UT Inc. Eli Lilly and Company v. Actavis Labs. UT Inc.
1:16-cv-01119, E.D. Va., Judges Nachmanoff, Trenga
Experience
Federal Circuit, district court, and arbitration victories protect Cumberland Pharmaceuticals’ flagship product, Acetadote® Federal Circuit, district court, and arbitration victories protect Cumberland Pharmaceuticals’ flagship product, Acetadote®
16-1155, -1259, Fed. Cir., Judges Moore, Reyna, Taranto
1:12-cv-03846, N.D. Ill., Judge Pallmeyer
Experience
Duchesnay, Inc. v. Actavis Laboratories Inc. and Mylan Pharmaceuticals, Inc. Duchesnay, Inc. v. Actavis Laboratories Inc. and Mylan Pharmaceuticals, Inc.
1:14-cv-00912, D. Del., Judges Robinson, Fallon
Experience
District court finds patent covering Cephalon’s wakefulness improving drug Nuvigil®, valid in ANDA litigation District court finds patent covering Cephalon’s wakefulness improving drug Nuvigil®, valid in ANDA litigation
1:10-md-02200, D. Del., Judge Sleet
Experience
U.S. Court finds patent covering AstraZeneca’s anti-cholesterol drug Crestor®, is valid and enforceable in ANDA litigation U.S. Court finds patent covering AstraZeneca’s anti-cholesterol drug Crestor®, is valid and enforceable in ANDA litigation
1:08-md-01949, D. Del., Judges Farnan, Stark
10-1460, -1461, -1462, -1463, -1464, -1465, -1466, -1467, -1468, -1469, -1470, -1471, -1472, -1473, Fed. Cir., Judges Mayer, Newman, Plager
Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.
We use cookies on this website to provide you with the best user experience. By accepting cookies, you agree to our use of cookies. Please note that if you opt not to accept or if you disable cookies, the “Your Finnegan” feature on this website will be disabled as well. For more information on how we use cookies, please see our Privacy Policy.
Finnegan is thrilled to announce the launch of our new blog, Ad Law Buzz, devoted solely to breaking news, developments, trends, and analysis in advertising law.